Rogers (ROG)

129.54 +1.18 (0.92%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/20/20 *Est.)

Latest Headlines

Promedior Enters Into Definitive Merger Agreement To Be Acquired By Roche November 15, 2019 7:30 AM - PR NewsWire Form 4 ROGERS CORP For: May 08 Filed by: BUCKLEY BENJAMIN MCNEIL November 12, 2019 4:51 PM - SEC Filing Genentech’s Risdiplam Meets Primary Endpoint in Pivotal SUNFISH Trial in People With Type 2 or 3 Spinal Muscular Atrophy November 11, 2019 1:00 AM - BizWire Genentech’s Gazyva (obinutuzumab), in Combination With Standard of Care, More Than Doubles the Percentage of Lupus Nephritis Patients Achieving Complete Renal Response, Compared to Standard of Care November 9, 2019 4:30 PM - BizWire Genentech to Present New Data Highlighting Breadth of Hematology Portfolio and Pipeline at the American Society of Hematology 2019 Annual Meeting November 6, 2019 11:45 AM - BizWire Rogers Corp (ROG) PT Lowered to $170 at Stifel November 1, 2019 7:56 AM - StreetInsider Rogers Corp (ROG) PT Lowered to $180 at B.Riley/FBR October 31, 2019 8:15 AM - StreetInsider Form 10-Q ROGERS CORP For: Sep 30 October 31, 2019 6:07 AM - SEC Filing Rogers (ROG) Tops Q3 EPS by 15c; Offers Q4 EPS/Revenue Guidance Below Consensus October 30, 2019 5:50 PM - StreetInsider Form 8-K ROGERS CORP For: Oct 30 October 30, 2019 4:11 PM - SEC Filing Rogers Corporation Reports Third Quarter 2019 Results October 30, 2019 4:09 PM - BizWire FDA Accepts Genentech’s Biologics License Application for Satralizumab for Neuromyelitis Optica Spectrum Disorder October 30, 2019 2:00 AM - BizWire Roche Diagnostics Announces Matthew Sause As Chief Executive Officer - North America October 28, 2019 10:35 AM - PR NewsWire U.S. charges six investment bankers over insider trading scheme October 22, 2019 5:54 PM - StreetInsider Genentech’s Tecentriq in Combination With Avastin Increased Overall Survival and Progression-free Survival in People With Unresectable Hepatocellular Carcinoma October 21, 2019 1:00 AM - BizWire Rogers Schedules Q3 2019 Earnings Call for October 30, 2019 October 18, 2019 2:14 PM - BizWire Genentech (RHHBY) Announces FDA Approval of Xofluza for People at High Risk of Developing Influenza-Related Complications October 17, 2019 11:36 AM - StreetInsider Genentech Announces FDA Approval of Xofluza (Baloxavir Marboxil) for People at High Risk of Developing Influenza-Related Complications October 17, 2019 11:35 AM - BizWire Roche Partners with iHeartMedia to Present 'iHeartCountry One Night For Our Military' Concert to Bring Further Awareness of The Impact Diabetes Has On The Nation's Veteran Population October 14, 2019 8:00 AM - PR NewsWire European stocks hit pause as trade doubts linger October 14, 2019 3:30 AM - StreetInsider Phase III PEMPHIX Study Shows Genentech’s Rituxan (rituximab) Superior to Mycophenolate Mofetil in Patients With Pemphigus Vulgaris October 14, 2019 1:00 AM - BizWire Genentech Presents Positive Phase III Results for Tecentriq (Atezolizumab) in Combination With Platinum-based Chemotherapy in People With Previously Untreated Advanced Bladder Cancer September 30, 2019 10:30 AM - BizWire Genentech to Present Results of First Prospective Trial Using Blood-based Next Generation Sequencing Which Successfully Identifies People for Treatment With Alecensa (Alectinib) September 30, 2019 2:30 AM - BizWire Genentech Granted FDA Approval of Rituxan in Children September 27, 2019 1:53 PM - StreetInsider FDA Approves Genentech’s Rituxan (rituximab) in Children With Two Rare Blood Vessel Disorders September 27, 2019 1:50 PM - BizWire Genentech’s Tecentriq (Atezolizumab) Improves Overall Survival as a First-line Monotherapy in Certain People With Advanced Non-small Cell Lung Cancer September 27, 2019 10:00 AM - BizWire Form 4 ROGERS CORP For: Sep 17 Filed by: LUDWIG MICHAEL M September 19, 2019 3:28 PM - SEC Filing FDA Grants Breakthrough Therapy Designation for Genentech’s Gazyva (Obinutuzumab) in Lupus Nephritis September 18, 2019 1:00 AM - BizWire Form 3 ROGERS CORP For: Sep 05 Filed by: Tsao Jeff September 13, 2019 8:31 AM - SEC Filing Banks sizzle as European stocks log fourth week of gains September 13, 2019 3:20 AM - StreetInsider Genentech Presents New Six-year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis September 13, 2019 1:03 AM - BizWire Genentech’s Fixed Dose Subcutaneous Combination of Perjeta and Herceptin Showed Non-Inferiority When Compared to Intravenous Formulations for People With HER2-Positive Breast Cancer September 13, 2019 1:00 AM - BizWire Genentech’s Satralizumab Significantly Reduced Relapse Risk in Second Positive Phase III Study for Neuromyelitis Optica Spectrum Disorder September 12, 2019 1:03 AM - BizWire Genentech’s Tecentriq (Atezolizumab) as a First-Line Monotherapy Helped Certain People With Advanced Non-Small Cell Lung Cancer Live Longer Compared With Chemotherapy September 12, 2019 1:00 AM - BizWire Genentech Presents New Ocrevus (Ocrelizumab) Biomarker Data That Increase Understanding of Disease Progression in Multiple Sclerosis at ECTRIMS September 10, 2019 1:00 AM - BizWire Form 8-K ROGERS CORP For: Sep 03 September 9, 2019 4:56 PM - SEC Filing Roche CEO touts drugs pipeline, rules out M&A just to boost sales September 6, 2019 11:09 AM - StreetInsider Inside drugmakers' strategy to boost cancer medicines with 'Lazarus effect' September 6, 2019 2:04 AM - StreetInsider Genentech to Present Pivotal Data for Satralizumab in Neuromyelitis Optica Spectrum Disorder and Six-year Ocrevus (Ocrelizumab) Data in Multiple Sclerosis at ECTRIMS September 4, 2019 1:00 AM - BizWire Roche, Spark again extend $4.3 billion takeover offer September 3, 2019 1:28 AM - StreetInsider Positive Phase III Results Show Xofluza (Baloxavir Marboxil) Reduces Risk of Developing the Flu After Contact With an Infected Person by 86 Percent September 2, 2019 1:10 AM - BizWire Genentech Presents Positive Phase III Study Results for One-dose Xofluza (Baloxavir Marboxil) in Children With the Flu September 2, 2019 1:00 AM - BizWire Full Article List